{"id":"W3021157979","doi":"10.1101/2020.05.11.20093146","title":"Nilotinib in Patients with Advanced Parkinson’s Disease: A Randomized Phase 2A Study (NILO-PD)","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Michael J. Fox Foundation for Parkinson's Research","keywords":"Tolerability; Placebo; Medicine; Internal medicine; Parkinson's disease; Nilotinib; Montreal Cognitive Assessment; Adverse effect; Disease; Dementia; Tyrosine kinase","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002029575,0.001211321,0.002198468,0.0004196719,0.0004409561,0.001049442,0.0005011683,0.001290247,0.004754554],"category_scores_gemma":[0.001115564,0.0005936473,0.001146322,0.0003187511,0.0008399215,0.0009715182,0.0004324379,0.001445985,0.0007422705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005853672,"about_ca_system_score_gemma":0.0009799214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003201288,"about_ca_topic_score_gemma":0.001146219,"domain_scores_codex":[0.9994537,0.0002788599,0.00004041794,0.0001060117,0.00004762924,0.00007334927],"domain_scores_gemma":[0.9995605,0.0000745677,0.00009684348,0.00002740611,0.0000434435,0.0001971427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9425622,0.01258506,0.002468334,0.001212709,0.001276314,0.0001269411,0.00008179816,0.0003136416,0.007197947,0.0001734642,0.001613197,0.03038842],"study_design_scores_gemma":[0.9183708,0.07685403,0.002600684,0.00003273402,0.0003601855,0.00007756457,0.0000218856,0.0002236327,0.0003152181,0.0001070544,0.001021416,0.00001476668],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788694,0.008688319,0.0009052417,0.0008856694,0.0004256607,0.006562751,0.001400656,0.0001501767,0.002112044],"genre_scores_gemma":[0.9840381,0.003215982,0.001733576,0.001352965,0.0003227262,0.005934146,0.001209597,0.00001917114,0.002173686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004754554,"threshold_uncertainty_score":0.01590556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01805245375242769,"score_gpt":0.307098422350753,"score_spread":0.2890459685983253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}